… the availability of up to $11 million in 2009 funding for research toward transformative treatments and a cure for … stage of the PD drug development pipeline. This includes early-stage discovery research, translational studies that … with a better understanding of how various programs fit into the larger context of the MJFF portfolio. Rapid …

… special "CBS Sunday Morning" interview. Michael shared his early vision for the Foundation -- to unite patients and researchers in a true partnership to accelerate research … in quarterly study visits that provide critical insights into the daily lived experience of Parkinson's disease. …

… The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has announced a new $2 million research initiative aimed at investigating the role … first step that has the potential to quickly translate into exciting new treatment options for PD patients, given …

… progression of Parkinson’s disease (PD) is growing, most research has not been inclusive of the broader community of … range of participants. “If preclinical and clinical PD research continues in its failure to include all who have … ensured treatments that work for all people with PD,” write research staff Bernadette Siddiqi and Andrew Koemeter-Cox, …

… of the year in its Hot Topics in Parkinson’s disease (PD) Research Seminar Series: "PD Research 2012: How Far We’ve Come and What Lies Ahead.” The … by MJFF CEO Todd Sherer , PhD, and Associate Director of Research Programs Maurizio Facheris , MD, MSc. During the …

… 16, 2016) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has launched the observational Systemic … The study aims to determine in which biofluids and tissues researchers should measure alpha-synuclein to diagnose PD, … — would revolutionize not only clinical care but also research. “A Parkinson’s biomarker would allow researchers …